Abstract
Accumulating evidence has suggested a role for the anti-apoptotic protein BCL2 in the development of autoimmune diseases, including type 1 diabetes mellitus (T1DM). Recently, the first BCL2 polymorphism (Ala43Thr) with association to T1DM in a Japanese population was reported. The polymorphism was found significantly more frequent in control individuals (14.5%) than in T1DM patients (6.8%), and was furthermore found to be functionally relevant, promoting a increased sensitivity to apoptosis when overexpressed in an IL-7 dependent mouse pre-B cell line. To investigate the relevance of the polymorphism in Caucasians, we have genotyped nearly 1400 individuals comprising Danish, Finnish and Basque T1DM family materials, using a PCR-based RFLP assay. In contrast to what was observed in Japanese diabetic/control individuals, we find no evidence for association of the BCL2 Ala43Thr polymorphism to T1DM in Danish, Finnish and Basque Type 1 diabetes families.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nerup J, Mandrup-Poulsen T, Helqvist S et al One the pathogenesis of IDDM Diabetologia 1994 37 (Suppl 2) 82–89
Mauricio D, Mandrup-Poulsen T Apoptosis and pathogenesis of IDDM. A question of life and death Diabetes 1998 47 1537–1543
Kroemer G The proto-oncogene Bcl-2 and its role in regulating apoptosis Nat Med 1997 3 614–620
Theofilopoulos AN, Kono DH The genes of systemic autoimmunity Proc Assoc Am Physicians 1999 111 228–240
Mountz JD, Wu J, Cheng J et al Autoimmune disease. A problem of defective apoptosis Arthritis Rheum 1994 37 1415–1420
Komaki S, Kohno M, Matsuura N The polymorphic 43Thr bcl-2 protein confers relative resistance to autoimmunity: an analytical evaluation Hum Genet 1998 103 435–440
Larsen ZM, Kristensen OP, Mato E et al IDDM12 (CTLA4) on 2q33 and IDDM13 on 2Q34 in genetic susceptibility to type 1diabetes (insulin dependent) Autoimmunity 1999 31 35–42
Pociot F, Veijola R, Johannesen J et al Analysis of a interferon-γ gene (IFNG) polymorphism in Danish and Finnish insulin-dependent diabtes mellitus (IDDM) patients and controlsubjects J Interferon Cytokine Res 1997 17 87–93
Nanclares GP, Bilbao JR, Nistico R et al No evidence of association of chromosome 2q with Type 1 diabetes in the Basque population Diabetologia 1999 42 119–120
Risch NJ Searching for genetic determinants in the new millennium Nature 2000 405 847–856
Johansson C, Castillejo-Lopez C, Johanneson B et al Association analysis with microsatellite and SNP markers does not support the involvement of BCL-2 in systemic lupus erythematosus in Mexican and Swedish patients and their families Genes Immun 2000 1 380–385
Merriman T, Twells R, Merriman M et al Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) to chromosome 18q21 Hum Mol Genet 1997 6 1003–1010
Kristiansen OP, Larsen ZM, Pociot F CTLA-4 in autoimmune diseases – a general susceptibility gene to autoimmunity? Genes Immun 2000 1 170–184
Merriman TA, Heather JC, Iain AE et al Suggestive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases Diabetes 2001 50 184–194
Gatenby PA, Irvine M The bcl-2 proto-oncogene is overexpressed in systemic lupus erythematosus J Autoimmun 1994 7 623–631
Mehrian R, Quismorio FP, Strassmann G Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus Arthritis Rheum 1998 41 596–602
Iwahashi H, Hanafusa T, Eguchi Y Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2 Diabetologia 1996 39 530–536
Rabinovitch A, Suarez-Pinzon W, Strynadka K Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects β-cells from cytokine-induced destruction Diabetes 1999 48 1223–1229
Bergholdt R, Larsen ZM, Andersen NA et al Characterization of new polymorphisms in the 5′UTR of the human interleukin-1 receptor type 1 (IL1R1) gene: linkage to type 1 diabetes and correlation to IL-1R1 plasma level Genes Immun 2000 1 495–500
Acknowledgements
The authors thank Drs J Johannesen and OP Kristensen, the DSGD, and the DIEGG for collecting part of the Danish families used in this study, and furthermore Dr Luis Castaño for generously providing the Basque material.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heding, P., Karlsen, A., Veijola, R. et al. No evidence of a functionally significant polymorphism of the BCL2 gene in Danish, Finnish and Basque type 1 diabetes families. Genes Immun 2, 398–400 (2001). https://doi.org/10.1038/sj.gene.6363788
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6363788
Keywords
This article is cited by
-
Does HCV Patients Who Have BCL2 43Ala Genotype and Normal GH1 Levels Can Achieve Response to IFN Based Therapy?
Indian Journal of Clinical Biochemistry (2012)
-
Identification of variants in cyclin D1 (CCND1) and B-Cell CLL/lymphoma 2 (BCL2)
Journal of Human Genetics (2004)
-
Genetics of type 1 diabetes mellitus
Genes & Immunity (2002)